m5C RNA-seq Services for Epitranscriptomics Research
5-methylcytosine (m5C) is a conserved RNA modification found across mRNA, tRNA, rRNA, and long non-coding RNAs. Deposited by methyltransferases of the NSUN family and DNMT2, m5C influences RNA stability, translation efficiency, and tRNA structure — with dysregulation increasingly linked to cancer, developmental disorders, and viral infection. At CD Genomics, we offer an integrated m5C RNA analysis platform covering both single-base resolution bisulfite sequencing (RNA-BS-seq) and antibody-based enrichment profiling (m5C RIP-seq/meRIP-seq), supported by expert bioinformatics. Whether your goal is to map precise m5C sites at nucleotide resolution or to survey transcriptome-wide methylation patterns for discovery, our team helps you match the right approach to your research question.
Key Highlights of Our m5C RNA-seq Services:
- Dual-Method Platform: RNA-BS-seq for single-base resolution and m5C RIP-seq / meRIP-seq for transcriptome-wide enrichment — choose the approach that fits your research question.
- Multi-RNA-Type Support: Optimized protocols for mRNA, tRNA, rRNA, and lncRNA — from poly(A) selection to targeted small RNA enrichment.
- End-to-End Bioinformatics: From raw data QC through methylation calling, differential analysis, motif discovery, and publication-ready visualizations.
- Species Flexibility: Support for model and non-model organisms, with RIP-seq compatible with de novo transcriptome assemblies.
Overview of Our m5C RNA-seq Services
5-methylcytosine (m5C) is a conserved RNA modification influencing RNA stability, translation efficiency, and tRNA structure. Deposited by NSUN family methyltransferases and DNMT2, its dysregulation is increasingly linked to cancer, developmental disorders, and viral infection. Profiling m5C at the transcriptome level has become an essential component of modern epitranscriptomics research. Our integrated m5C analysis platform combines single-base resolution bisulfite sequencing (RNA-BS-seq) with antibody-based enrichment profiling (m5C RIP-seq/meRIP-seq), supported by expert bioinformatics and multi-RNA-type workflows covering mRNA, tRNA, rRNA, and lncRNA.
Core Technologies for m5C RNA Profiling
RNA Bisulfite Sequencing (RNA-BS-seq) — Single-Base Resolution
RNA bisulfite sequencing is the gold standard for m5C detection at single-nucleotide resolution. Sodium bisulfite treatment converts unmethylated cytosines (C) to uracils (U), while 5-methylcytosine remains protected and is read as C during sequencing. By comparing treated and untreated RNA, every m5C site across the transcriptome can be identified with base precision and methylation stoichiometry estimated per position.
A 2024 study in Life Science Alliance re-analyzed bisulfite RNA-seq data from five human cell lines and seven tissues, yielding 6,393 high-confidence m5C sites and defining the hierarchical contributions of NSUN2, NSUN6, and NSUN5 as mRNA m5C writers (Guarnacci et al., 2024). This level of precision — mapping individual modification sites to specific methyltransferases — is unique to BS-seq. Our RNA-BS-seq service supports poly(A)-selected mRNA, rRNA-depleted total RNA, and targeted tRNA enrichment. See our dedicated mRNA m5C BS-seq page for method-specific details.
m5C RIP-seq and m5C meRIP-seq — Transcriptome-Wide Enrichment
m5C RIP-seq (RNA Immunoprecipitation Sequencing) and m5C meRIP-seq (Methylated RNA Immunoprecipitation Sequencing) use specific antibodies raised against 5-methylcytosine to enrich m5C-containing RNA fragments, followed by sequencing to identify methylated regions transcriptome-wide. These methods provide regional resolution (~100–150 nucleotides), making them well-suited for discovery-phase profiling and comparative analysis between conditions. Compared to BS-seq, RIP-seq requires lower sequencing depth per sample and offers higher sensitivity for low-abundance transcripts due to the enrichment step — ideal for multi-sample screening studies.
Additional m5C Detection Methods
For specialized applications, we also offer miCLIP-m5C-seq (crosslinking-based single-nucleotide resolution targeting NSUN2-dependent sites) and can discuss Oxford Nanopore direct RNA-seq for native modification detection — see our ONT Direct RNA Sequencing page for details.
How to Choose Between BS-seq and RIP-seq for m5C Analysis
Selecting the right m5C detection method depends on your resolution requirement, sample situation, and research goals.
| Criterion | RNA-BS-seq | m5C RIP-seq / meRIP-seq |
|---|---|---|
| Resolution | Single-base (nucleotide) | Regional (~100–150 nt) |
| Coverage | Transcriptome-wide, unbiased | Transcriptome-wide, antibody-enriched |
| Methylation stoichiometry | Yes (C/T ratio per site) | No (enrichment fold-change) |
| Sensitivity for low-abundance RNA | Moderate (requires deep sequencing) | High (antibody enrichment) |
| Sequencing depth needed | Higher | Lower |
| Antibody required | No | Yes (anti-m5C) |
| Non-model organism support | Requires reference genome | Reference or de novo transcriptome |
| Best for | Precise site ID, stoichiometry, writer/substrate mapping | Discovery screening, multi-condition comparison, low-input |
Selection Strategy:
- Define your resolution requirement. If you need to know the exact nucleotide position and methylation level of each m5C site — for example, to map NSUN2 substrate specificity or validate a regulatory site — RNA-BS-seq is the appropriate choice. If your goal is to identify which transcripts and pathways carry m5C marks across conditions, m5C RIP-seq will be sufficient.
- Consider your sample. Limited RNA amounts or low-abundance transcripts favor RIP-seq due to the enrichment step. For stoichiometric quantification per site, BS-seq is necessary.
- Combine for completeness. An increasingly common strategy is RIP-seq for discovery-phase screening, followed by BS-seq validation of key sites on selected samples.
- For non-model organisms. RIP-seq works with de novo transcriptome assemblies; BS-seq requires a reference genome for accurate alignment and methylation calling.
End-to-End Workflow and Quality Control
Our m5C RNA-seq service follows a standardized workflow with QC checkpoints at every stage. Two parallel routes — BS-seq and RIP-seq — diverge at library preparation before converging on shared sequencing and bioinformatics.
- Sample Receipt and Quality Assessment — QC Checkpoint: RNA integrity (RIN) verification via Bioanalyzer/TapeStation; concentration and purity (OD260/280) measurement; degradation and contamination assessment.
- RNA Preparation — QC Checkpoint: Poly(A) selection or rRNA depletion efficiency verified by Bioanalyzer; RNA yield post-enrichment confirmed. For tRNA studies, small RNA enrichment confirmed.
- Library Construction — QC Checkpoint (BS-seq): Bisulfite conversion efficiency (>99%) via spike-in controls; fragment size; library yield. QC Checkpoint (RIP-seq): Antibody enrichment efficiency by qPCR of control transcripts; fragment size; library yield.
- Sequencing — QC Checkpoint: Yield and Q30 scores; duplication rate; PhiX alignment rate; read-level C→T conversion rate for BS-seq libraries.
- Data Quality Control — QC Checkpoint (BS-seq): Conversion efficiency from read-level C→T rates at non-methylated positions; alignment rates; coverage uniformity. QC Checkpoint (RIP-seq): Peak enrichment signal-to-noise; FRiP; replicate correlation; library complexity.
- Bioinformatics and Report Delivery — QC Checkpoint: Peak/methylation call reproducibility; differential analysis statistical metrics; deliverable completeness; final QC summary.
Sample Requirements and Preparation Guidelines
Proper sample handling is essential for m5C RNA analysis. RNA is susceptible to degradation — compromised samples can introduce bias in methylation detection.
| Method | Recommended RNA Type | Input Guideline | Key QC Metrics | Notes |
|---|---|---|---|---|
| RNA-BS-seq (mRNA) | Poly(A)-selected mRNA | ≥ 30 μg total RNA recommended; ≥ 10 μg minimum; ≥ 20 ng/μL | RIN ≥ 7; OD260/280: 1.8–2.1 | Higher input recommended due to RNA loss during bisulfite treatment |
| RNA-BS-seq (total RNA) | rRNA-depleted total RNA | ≥ 30 μg total RNA recommended; ≥ 10 μg minimum; ≥ 20 ng/μL | RIN ≥ 7; OD260/280: 1.8–2.1 | rRNA depletion maximizes m5C signal from mRNA and ncRNA |
| m5C RIP-seq / meRIP-seq | Total RNA or poly(A)-selected | Project-specific — contact us | RIN ≥ 7; OD260/280: 1.8–2.1 | Lower input feasible due to enrichment; anti-m5C antibody validated per batch |
| tRNA m5C BS-seq | Enriched small RNA (<200 nt) | Project-specific — contact us | Small RNA enrichment confirmed | Requires dedicated tRNA/small RNA purification |
All samples should be shipped on dry ice and stored at -80°C. Avoid repeated freeze-thaw cycles.
Bioinformatics Analysis and Deliverables
All m5C RNA-seq services include standard bioinformatics processing with the option to add advanced analysis modules.
Standard Deliverables:
| Deliverable | Description |
|---|---|
| Raw sequencing data | Demultiplexed read files with quality scores |
| Aligned reads | Reads aligned to reference genome/transcriptome |
| Methylation calls (BS-seq) | Per-site m5C positions with methylation ratio |
| Signal tracks (RIP-seq) | Normalized enrichment tracks for browser visualization |
| Peak calls (RIP-seq) | Enriched m5C regions with statistical significance |
| QC report | Conversion efficiency, alignment rates, FRiP, coverage metrics |
| Differential methylation analysis | Comparison between conditions with statistical tests |
| Motif analysis | Sequence motifs enriched around m5C sites or peaks |
| Peak / site annotation | Genomic context with nearest gene/transcript |
| GO/KEGG enrichment | Functional enrichment of m5C-modified genes |
Optional Advanced Analysis:
- Multi-omics integration — combined m5C data with matched RNA-seq, m6A-seq, or proteomics
- Writer/reader target prediction — integration with public CLIP-seq and protein-RNA interaction databases
- tRNA-specific m5C analysis — specialized pipelines for tRNA modification calling and stoichiometry
- ONT direct RNA-seq analysis — native RNA modification detection without bisulfite or amplification
- Custom visualization — publication-ready figures including circos plots, heatmaps, and integrative browser views
- Epigenomic data analysis — see our dedicated Epigenomic Data Analysis service
Representative Data and Demo Results
Below are representative data types delivered with each m5C analysis project. All panels represent standard bioinformatics outputs generated by our pipeline, reflecting the quality and depth researchers can expect.
BS-seq Quality and Site-Level Outputs:
- Single-base m5C methylation track — IGV-style genome browser view showing read-level C→T conversion evidence with per-site methylation ratio. Each dot represents a cytosine position; the ratio of C to T reads directly quantifies methylation stoichiometry.
- m5C site distribution summary — breakdown of identified m5C sites across RNA biotypes (mRNA CDS, 5'UTR, 3'UTR, tRNA, rRNA, lncRNA), showing the global distribution of 5-methylcytosine across the transcriptome.
- Sequence motif logo — consensus sequence context surrounding high-confidence m5C sites, identifying preferred nucleotide motifs associated with NSUN family methyltransferase targeting.
RIP-seq Enrichment and Differential Analysis:
- m5C enrichment peak track — normalized read coverage across a representative transcript with called peak regions indicated, showing the regional nature of RIP-seq signal.
- Differential m5C volcano plot — each point represents a called m5C peak; x-axis log2 fold change between conditions; y-axis -log10 adjusted p-value. Hyper- and hypo-methylated regions surpassing the significance threshold are color-highlighted.
- GO/KEGG enrichment bar chart — top enriched biological process terms among genes harboring differentially methylated m5C peaks, providing functional interpretation of the m5C landscape.
All demo results are generated from representative datasets and reflect the standard analysis depth delivered with every project. Actual figures are customized to your experimental design, sample type, and research question.
Applications Across Research Areas
m5C modifications play emerging roles across multiple cancer types. In anaplastic thyroid cancer, NSUN2-mediated tRNA m5C stabilizes tRNAs and drives codon-biased oncogenic translation, contributing to chemoresistance (Li et al., Clinical and Translational Medicine, 2023). In hepatocellular carcinoma, m5C-RIP-Seq revealed NSUN2 hypermethylation of PKM2 mRNA at C773 in the 3'UTR, enhancing glycolysis (Cell Death & Disease, 2025). In non-small cell lung cancer, NSUN2-driven NRF2 mRNA m5C promotes ferroptosis resistance.
tRNAs are among the most heavily modified RNA species, and m5C at positions C48/C49 in the variable loop directly affects tRNA stability, aminoacylation efficiency, and codon-biased translation. RNA bisulfite sequencing targeting the tRNA fraction provides base-resolution m5C maps across the tRNA repertoire, enabling functional studies of how tRNA modifications shape the cellular translatome.
The NSUN family of methyltransferases shows tissue-specific and developmental-stage-specific expression. Profiling m5C across differentiation time courses identifies regulatory methylation events controlling cell fate decisions and reveals developmental windows sensitive to epitranscriptomic disruption.
m5C modifications influence host innate immune responses and viral replication. A 2024 review in Frontiers in Immunology highlighted the role of m5C in SARS-CoV-2-associated myocarditis. In plants, m5C is conserved across kingdoms, and profiling in crop species under stress conditions can reveal epitranscriptomic adaptation mechanisms for agricultural biotechnology.
Case Study: NSUN2-mediated tRNA m5C Stabilization in Anaplastic Thyroid Cancer
Frequently Asked Questions
References
- Guarnacci et al., Life Science Alliance (2024). Substrate diversity of NSUN enzymes and links of 5-methylcytosine to mRNA translation and turnover. https://doi.org/10.26508/lsa.202402613
- Li P. et al., Clinical and Translational Medicine (2023). The m5C methyltransferase NSUN2 promotes codon-dependent oncogenic translation by stabilising tRNA in anaplastic thyroid cancer. https://doi.org/10.1002/ctm2.1466
- Cell Death & Disease (2025). The RNA m5C methyltransferase NSUN2 promotes progression of hepatocellular carcinoma by enhancing PKM2-mediated glycolysis. https://doi.org/10.1038/s41419-025-07414-5
- Frontiers in Immunology (2024). RNA m5C methylation modification: a potential therapeutic target for SARS-CoV-2-associated myocarditis. https://doi.org/10.3389/fimmu.2024.1380697